Navigation Links
Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health

HERNDON, Va., Dec. 12 /PRNewswire/ -- Cascades Technologies, Inc. (CTi), a professional consulting firm for the federal government, together with Science Applications International Corporation (NYSE: SAI), announced the award of a contract with the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract to SAIC is for $19 million over a seven-year period of performance. CTi will provide regulatory affairs, technical and administrative support for clinical research programs through this contract.

CTi's role will be focused on technical services. Among other tasks, CTi will maintain and operate a regulatory management database for NIAID known as the Human Subject Research Oversight and Accountability Database (HSROAD). CTi will also investigate new and improved technologies to enhance the efficiency and ease of use of this database. In addition, CTi will assist SAIC with system security for the database system.

CTi joined the SAIC team after having provided technical support to one of NIAID's divisions for the past eight years. CTi originally designed and built the HSROAD database and has a long track record of successful performance. "We are excited about continuing to support the vital mission of NIAID as well as NIH in general," stated Alfredo Casta, President/CEO of CTI. He added, "We are proud to team with SAIC to ensure the clinical research supported by NIAID is as effective as possible in saving lives and improving the health of people all over the world."

"We look forward to applying our expertise in biomedical and regulatory affairs to a program that improves national and global health through clinical research and development of new drugs, biologics and devices to treat or prevent infectious diseases," said Robert McCord, SAIC senior vice president and business unit general manager.

Cascades Technologies, Inc. (CTi), is a customer-focused professional consulting firm committed to acting as a reliable advisor to its clients; driving efficiency and productivity, resulting in improved services. From diagnosis to solutions, CTi identifies areas of improvement and helps deliver results, including customized technology applications specific to the client's needs. An 8(a) certified, Hispanic-owned business, CTi's primary customers are civilian agencies within the Federal government and various health related entities. CTi is on the GSA IT-70 Schedule and has multiple contract vehicles in place with several federal agencies. In addition to its Herndon, VA headquarters, CTi has established offices in Washington, DC, and San Juan, Puerto Rico.

To learn more about Cascades Technologies, Inc. (CTi), call 703.793.7222 or visit

SOURCE Cascades Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GSA Selects Cascades Technologies, Inc. (CTi) to Support
2. Cascades Technologies, Inc. Chosen to Deliver IT Support on a DoD Blast Injury Research Program
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
6. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
7. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
8. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
9. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
10. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
11. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
Breaking Biology Technology:
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):